The fact that individuals with type 2 diabetes have elevated fasting glucose levels is among the most perplexing factors for them. This is due to the fact that in these insulin-resistant individuals, the liver produces glucose, a process that still raises many unanswered issues for scientist
New Delhi [India], May 31: A groundbreaking study sheds light on a silent health crisis gripping our cities. One-third of urban Indians [1] grapple with metabolic syndrome, a condition disproportionately affecting women. This complex web of high blood sugar, unhealthy cholesterol, high blood
The efficacy of a medication to prevent liver fat accumulation--a condition that frequently coexists with obesity and can result in dangerous fatty liver disease--has been further explored by researchers at the University of Oklahoma.
Mumbai (Maharashtra) [India], April 10: Roche Diagnostics India announces the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of cardiovascular diseases (CVD) such as heart failure (HF). This breakthrough innovation is designed to bring testing clos
Disease management is critical to avoiding long-term complications, including limb amputations or heart problems. To avoid negative outcomes, it is critical that patients understand how to manage their disease on a daily basis.
Type 2 diabetes (T2D), a chronic condition affecting hundreds of millions of people worldwide, is commonly caused by the body's inability to make enough insulin or use it correctly. problems care is critical for avoiding long-term complications such as limb amputation or heart problems. To a
According to new research, nearly 500 adults with obesity who took the new weight loss medication tirzepatide for about eight months saw a significant reduction in their systolic blood pressure--the top number in a blood pressure reading.
Researchers at Harvard Pilgrim Health Care Institute conducted a new study of current literature, revealing that female reproductive features may be ignored as risk factors for later metabolic disorders.
Researchers at Mass General Brigham discovered that using sodium-glucose contratransporter 2 (SGLT2) inhibitors was associated with a decreased chance of acquiring kidney stones. Their findings were published in JAMA Internal Medicine.
Researchers at the Harvard Pilgrim Health Care Institute have conducted a fresh analysis of the current literature, which reveals that female reproductive characteristics may be ignored as risk factors for later metabolic dysfunction.
Mumbai (Maharashtra) [India], January 9: Diabetes and weight issues in corporate employees lead to decreased productivity and higher healthcare costs. According to a study1, the average annual expenditure on Type 2 diabetes in India amounts to around INR 14,000 and over INR 3,50,000 over a l